Stay updated on Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial page.

Latest updates to the Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial page
- Check2 days agoChange DetectedAdded related topics Rheumatoid arthritis and MedlinePlus Genetics to the page. These additions provide background information but do not affect the study details or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check10 days agoChange DetectedExpanded Locations section now lists numerous study sites across the United States and internationally, including the Revision: v3.3.3.SummaryDifference2%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedRheumatoid arthritis is added as a primary condition on the page, and a related topics section now includes MedlinePlus Genetics. These changes provide direct context for the study and link to additional resource information.SummaryDifference0.1%

- Check39 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and updated the revision label to v3.3.2; older PubMed explanatory text and topic list were removed.SummaryDifference0.1%

- Check47 days agoChange DetectedNotice about lapse in government funding was removed from the page. The study details, eligibility criteria, and locations list remain the same.SummaryDifference0.1%

- Check61 days agoChange DetectedAdded related topics: Rheumatoid arthritis and MedlinePlus Genetics to the Study Details page.SummaryDifference0.1%

Stay in the know with updates to Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Placebo in RA on csDMARDs: Clinical Trial page.